2023. Profile of sales and notifications of suspected adverse events related to hydroxychloroquine and chloroquine during the COVID-19 pandemic. Research, Society and Development. 12, 2 (Jan. 2023), e15112240021. DOI:https://doi.org/10.33448/rsd-v12i2.40021.